UAB "LEVIPHARM" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,540 |
| 2,540 |
| 957 |
| -957 |
| -957 |
| -41.97 |
| -37.68 |
| 5,077 |
| 540 |
| 0 |
| 5,617 |
| 2023 |
|---|
| 4,230 |
| 4,230 |
| 1 |
| -1 |
| -1 |
| 34.54 |
| -0.02 |
| 5,077 |
| 1,603 |
| 0 |
| 6,680 |
| 2024 |
|---|
| 3,960 |
| 3,960 |
| 4,775 |
| -4,775 |
| -4,775 |
| 21.79 |
| -120.58 |
| 341 |
| 883 |
| 0 |
| 1,224 |
Register and
explore Okredo data| 2024 |
|---|
| 3,960 |
| 3,960 |
| 4,775 |
| -4,775 |
| -4,775 |
| 21.79 |
| -120.58 |
| 341 |
| 883 |
| 0 |
| 1,224 |
Register and
explore Okredo data2024
Turnover (€)
3,960 €
-6 % *
Sales per employee (€)
3,960 €-6 % *
Profit before tax (€)
4,775 €
477,400 % *
Net Profit (€)
-4,775 €-477,400 % *
Profit per employee (€)
-4,775 €-477,400 % *
Total profitability (%)
21.79 %-36.91 % *
Net profitability (%)
-120.58 %-602,800.00 % *
Equity (€)
341 €-93 % *
Amounts Payable And Liabilities (€)
883 €
-45 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
1,224 €-82 % *